BONESUPPORT appoints Annelie Aava Vikner as Executive Vice President Global Marketing & Communications

Lund, Sweden, 8:00 CET, January 4 2019 – BONESUPPORT™ an emerging leader in Orthobiologics for the management of bone voids, announces changes in its leadership team that will take place March 1, 2019. Annelie Aava Vikner starts in a new position as the company´s Executive Vice President Global Marketing & Communications. Annelie Aava Vikner has more than 15 years of experience from various marketing management positions at Medtronic, the USA founded healthcare technology company. Most recently she functioned as Senior Strategy & Marketing Manager Austria, Switzerland, Benelux, Greece, Israel & Nordic.

“Annelie Aava Vikner will be an important addition to the BONESUPPORT leadership team. Her experience will be of value for the exciting time ahead of us. Additionally, I want to thank Linda Butcher for her achievements as Chief Marketing Officer. Linda takes on the role as Vice President of Training & Events” says Emil Billbäck, BONESUPPORT CEO.

For more information contact:

BONESUPPORT AB

Emil Billbäck, CEO

+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46(0) 46 286 53 70
ir@bonesupport.com

Citigate Dewe Rogerson

Pip Batty, David Dible, Shabnam Bashir

+44 (0)20 7638 9571

bonesupport@citigatedewerogerson.com

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. The company is based in Lund, Sweden, and the net sales amounted to SEK 129 million in 2017. Please visit www.bonesupport.com for more information.

BONESUPPORT® and CERAMENT® are registered trademarks

News

New application programme open for experienced researchers
14. January 2019
Transparent mice map the brain’s washing machine
4. January 2019
Lundbeck Foundation invests in treatment for rare tumours
4. January 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge